Podcast 1 Mar 2024
The final chapter in genomic medicines?
Explore the future of genomic medicine with Tome Biosciences’ programmable genomic integration technique, set to revolutionize gene editing.
- Latest Posts
Best in Biotech 29 Feb 2024
6 biotech companies making a difference in pediatric care
Take a closer look at six pediatric companies taking innovative approaches to tackle illnesses affecting children.
In Depth 28 Feb 2024
Beyond fundraising: how do venture capitals build early-stage biotechs?
Venture capitals can help build early-stage biotech startups and boost innovation in the life science industry.
Best in Biotech 27 Feb 2024
Japan’s ten hottest biotech companies in healthcare
While Japan historically lacked foreign investment the field is becoming more dynamic. Discover ten essential biotech companies in Japan.
In Depth 27 Feb 2024
Can the Novo Holdings-Catalent deal set a new standard for Pharma M&A?
Explore the strategic implications of Novo Nordisk’s $16.5B Catalent acquisition on drug supply and market competition.
Protein inhibitors: cracking the code of disease mechanisms
Explore how protein inhibitors revolutionize disease understanding, by unlocking the secrets of disease pathways.
ADVERTISEMENT
ADVERTISEMENT
Expert Advice 23 Feb 2024
Navigating the life sciences job market: Five job boards making your life easier
Discover five life sciences-specialized job boards to make your job search easier in our article spotlighting the most effective options.
Podcast 23 Feb 2024
Precision neuromedicine: A new dawn for neurological disorders
This week on our podcast, explore how precision neuromedicine is reshaping neurological care with Rapport Therapeutics.
In Depth 22 Feb 2024
TIL therapies: the impact on cancer research
The approval of the first-ever TIL therapy has made it possible to treat hundreds of thousands of people affected by skin cancer in the US.
Best in Biotech 22 Feb 2024
10 gene therapy companies you should know about
Explore 10 gene therapy companies operating within the biotech industry, as each one hopes to develop their own novel candidates.
In Depth 21 Feb 2024
Cytokine release syndrome: how pharma is tackling a 21st century disease
Explore the frontier of biotech’s battle against cytokine release syndrome (CRS), from historical setbacks to cutting-edge solutions.
Best in Biotech 20 Feb 2024
Biotechs in the US Capital: seven key players based in Washington DC
Dive into the vibrant biotech scene of Washington D.C. with our article spotlighting the pioneering biotech companies leading the charge.
ADVERTISEMENT
